RDY (Dr Reddy's Laboratories) Total Equity : $3,691 Mil (As of Sep. 2024)

View and export this data going back to 2001. Start your Free Trial

What is Dr Reddy's Laboratories Total Equity?

Dr Reddy's Laboratories's total equity for the quarter that ended in Sep. 2024 was $3,691 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Dr Reddy's Laboratories Total Equity Historical Data

The historical data trend for Dr Reddy's Laboratories's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dr Reddy's Laboratories Total Equity Chart

Dr Reddy's Laboratories Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Total Equity

Get a 7-Day Free Trial

2,079.03

2,376.59

2,500.70

2,807.84

3,379.25

Dr Reddy's Laboratories Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Total Equity	Get a 7-Day Free Trial															3,046.66	3,217.26	3,379.25	3,530.16	3,691.12

Dr Reddy's Laboratories Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Dr Reddy's Laboratories's Total Equity for the fiscal year that ended in Mar. 2024 is calculated as

Total Equity	=	Total Assets(Q: Mar. 2024 )	-	Total Liabilities(Q: Mar. 2024 )
	=	4667.688	-	1288.439
	=	3,379

Dr Reddy's Laboratories's Total Equity for the quarter that ended in Sep. 2024 is calculated as

Total Equity	=	Total Assets(Q: Sep. 2024 )	-	Total Liabilities(Q: Sep. 2024 )
	=	5560.919	-	1869.795
	=	3,691

Dr Reddy's Laboratories Total Equity Related Terms

Thank you for viewing the detailed overview of Dr Reddy's Laboratories's Total Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Dr Reddy's Laboratories Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Dr Reddy's Laboratories Ltd (NYSE:RDY) » Definitions » Total Equity

Traded in Other Exchanges

DRREDDY:India 500124:India RDDA:Germany RDDA:Germany R1DY34:Brazil

Address

8-2-337, Road No. 3, Banjara Hills, Hyderabad, TG, IND, 500 034

Website

https://www.drreddys.com

Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (about 20% of its generics sales), Russia (10%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.